Part, Chapter, Paragraph
1 I, 1,1(10)| associated with systemic complement activation in a pig-to-primate
2 I, 2,2 | xenoreactive natural antibodies and complement of the recipient acting
3 I, 2,2 | xenoreactive natural antibodies and complement are the two major factors
4 I, 2,2(13)| et al., Mechanisms of complement activation in the hyperacute
5 I, 2,2 | antibodies fix and activate complement, with the combination of
6 I, 2,2 | antibodies and activated complement leading to endothelial activation
7 I, 2,2 | by methods that inhibit complement.(16) ~Among the different
8 I, 2,2 | achieving inhibition of complement, the one that has proven
9 I, 2,2 | protein that inhibits human complement activation is introduced
10 I, 2,2(16)| J., et al., Role of the complement system in graft rejections
11 I, 2,2(16)| The effect of soluble complement receptor type 1 on hyperacute
12 I, 2,2(16)| Dalmasso A.P., et al., Complement inhibition with an anti-C5
13 I, 2,2(17)| Bach F.H., Inhibition of complement mediated endothelial cell
14 I, 2,2(18)| Expression of a functional human complement inhibitor in a transgenic
15 I, 2,2(18)| Alvarado C.G., et al., Human complement regulatory proteins protect
16 I, 2,2(18)| for a human regulator of complement activation, Transplant Proc
17 I, 2,3 | together with recipient complement, lead to rejection of the
18 I, 2,3 | anti-graft antibodies and complement. Short-term inhibition of
19 I, 2,3 | Short-term inhibition of complement coupled with continuing
20 I, 2,3(30)| anti-donor antibodies and complement that precipitate rejection
21 I, 2,3 | other human genes inhibiting complement cascade, coupled with immunosuppression
22 I, 2,3(33)| Alvarado C.G., et al., Human complement regulatory proteins protect
23 I, 2,3(34)| Alvarado C.G., et al., Human complement regulatory proteins protect
|